Prev Next


(1) The department adopts and incorporates by reference the following publications:

(a) The "Control of Communicable Diseases Manual, An Official Report of the American Public Health Association", 21st edition, 2022, which lists and specifies control measures for communicable diseases.

(b) The "2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings," published by the U.S. Centers for Disease Control and Prevention, which specifies precautions that should be taken to prevent transmission of communicable diseases for cases admitted to a hospital or other health care facility.

(c) The "Sexually Transmitted Infections Treatment Guidelines, 2021,"  published by the U.S. Centers for Disease Control and Prevention in the July  23, 2021, Morbidity and Mortality Weekly Report, volume 70, hereafter referred to as "Sexually Transmitted Infections Treatment Guidelines, 2021," and specify the most currently accepted effective treatments for sexually transmitted infections.

(d) The "Food Code, 2013, Recommendations of the United States Public Health Service, Food and Drug Administration," published by the National Technical Information Service.

(e) The Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis, published in Clinical Infectious Diseases, October 1, 2016.

(f) The "Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis," which provide recommendations from the National Tuberculosis Controllers Association and the U.S. Centers for Disease Control and Prevention, published December 16, 2005.

(g) The "Interim Guidance for a Public Health Response to Contain Novel or Targeted Multidrug-resistant Organisms (MDROs)", updated January 2019, published by the U.S. Centers for Disease Control and Prevention, which serves as general guidance to state and local health departments and healthcare facilities in relation to the initial response for the containment of novel or targeted MDROs or resistance mechanisms.

(2) To obtain, or for information on how to obtain, any document or publication incorporated by reference, contact the Department of Public Health and Human Services, Public Health and Safety Division, Epidemiology and Scientific Support, 1400 Broadway, P.O. Box 202951, Helena, MT 59620-2951, phone: (406) 444-0273, or by visiting its website at: https://dphhs.mt.gov/publichealth/cdepi/reporting.  


History: 50-1-202, MCA; IMP, 50-1-202, MCA; NEW, 2006 MAR p. 2112, Eff. 9/8/06; AMD, 2013 MAR p. 967, Eff. 6/7/13; AMD, 2017 MAR p. 343, Eff. 3/25/17; AMD, 2019 MAR p. 1745, Eff. 1/1/20; AMD, 2022 MAR p. 1855, Eff. 9/24/22.

Home  |   Search  |   About Us  |   Contact Us  |   Help  |   Disclaimer  |   Privacy & Security